Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Saturday Links

Posted on November 22, 2025November 21, 2025 by John C. Goodman

Among 184 cancer drugs analyzed, 41.8 percent had at least one follow-on approval, with 59.7 percent of those targeting earlier disease stages than the original approval. This type of innovation is threatened by the IRA, which shortened the period of patent protection.

Nearly 70,000 federal employees make more than $200,000, or two and a half times the median household income.

Less than 60% of males between the ages of 16-24 are working. 

Capretta’s ACA reform: let low-wage workers have a partial subsidy to buy into their employer’s plan.

Mark Cuban wants to F___ Up health care. (Statnews)

Study: healthy lifestyle habits improve engagement at work.

3 thoughts on “Saturday Links”

  1. Devon Herrick says:
    November 22, 2025 at 3:36 pm

    Last link: I suspect that healthy lifestyle habits are correlated with engagement at work for similar reasons. Both indicate efforts to boost future benefits. Thus, healthy lifestyle habits are not causal, just correlated.

    Loading...
    Reply
  2. Devon Herrick says:
    November 22, 2025 at 3:41 pm

    1st link (patents):can’t a cancer drug approved for one cancer be used off-label for others? Do we really need to extend patent life to encourage additional testing? Patents boost innovation, but can also slow innovation. What incentive do drugmakers have to release the new and improved version while their old version is still protected? It similar to the Laffer Curve.

    Loading...
    Reply
  3. Bart Ingles says:
    November 23, 2025 at 2:32 pm

    On the Capretta link, a small subsidy to offset the reduced value of the tax exclusion for workers below 200% FPL seems rational, but perhaps not-so-timely when the clock is ticking for Republicans on how to handle subsidies for ACA consumers over 400% FPL. I hope they can find a way to soften the benefit cliff without returning to premium caps and unlimited federal funding. Doing nothing will probably result in an eventual return to Democrat control and reinstatement of the IRA subsidies.
    A principled approach toward replacing the lapsed IRA subsidy could be to offset the portion of ACA premiums that are effectively a tax on healthy members. The form of the subsidy should be one that fits this rationalization. Perhaps a fixed dollar amount credit to offset ACA premiums, or else a fixed percentage of the premium for a silver plan.

    Loading...
    Reply

Join the conversation.Cancel reply

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 40 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom
%d